Literature DB >> 17711427

Death effector activation in the subventricular zone subsequent to perinatal hypoxia/ischemia.

Michael J Romanko1, Changlian Zhu, Ben A Bahr, Klas Blomgren, Steven W Levison.   

Abstract

Perinatal hypoxia/ischemia (H/I) is the leading cause of neurological injury resulting from birth complications and pre-maturity. Our studies have demonstrated that this injury depletes the subventricular zone (SVZ) of progenitors. In this study, we sought to reveal which cell death pathways are activated within these progenitors after H/I. We found that calpain activity is detected as early as 4 h of reperfusion and is sustained for 48 h, while caspase 3 activation does not occur until 8 h and peaks at 24 h post-insult. Activated calpains and caspase 3 co-localized within precursors situated in the lateral aspects of the SVZ (which coincides with progenitor cell death), whereas neither enzyme was activated in the medial SVZ (which harbors the neural stem cells that are resilient to this insult). These studies reveal targets for neuroprotective agents to protect precursors from cell death towards the goal of restoring normal brain development after H/I.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711427     DOI: 10.1111/j.1471-4159.2007.04820.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Altered fate of subventricular zone progenitor cells and reduced neurogenesis following neonatal stroke.

Authors:  Ruggero Spadafora; Fernando F Gonzalez; Nikita Derugin; Michael Wendland; Donna Ferriero; Patrick McQuillen
Journal:  Dev Neurosci       Date:  2010-05-04       Impact factor: 2.984

Review 2.  MicroRNAs in brain development and cerebrovascular pathophysiology.

Authors:  Qingyi Ma; Lubo Zhang; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2019-03-06       Impact factor: 4.249

Review 3.  Development of the cerebral cortex and the effect of the intrauterine environment.

Authors:  Sebastian Quezada; Margie Castillo-Melendez; David W Walker; Mary Tolcos
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

Review 4.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

5.  Molecular features of neural stem cells enable their enrichment using pharmacological inhibitors of survival-promoting kinases.

Authors:  Christine Y Brazel; Abdulaziz A Alaythan; Ryan J Felling; Frances Calderon; Steven W Levison
Journal:  J Neurochem       Date:  2013-10-10       Impact factor: 5.372

6.  bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death.

Authors:  K C Walls; Arindam P Ghosh; Mary E Ballestas; Barbara J Klocke; Kevin A Roth
Journal:  J Neuropathol Exp Neurol       Date:  2009-12       Impact factor: 3.685

7.  Apoptosis-inducing factor downregulation increased neuronal progenitor, but not stem cell, survival in the neonatal hippocampus after cerebral hypoxia-ischemia.

Authors:  Yanyan Sun; Yu Zhang; Xiaoyang Wang; Klas Blomgren; Changlian Zhu
Journal:  Mol Neurodegener       Date:  2012-04-25       Impact factor: 14.195

8.  Ionizing Radiation Perturbs Cell Cycle Progression of Neural Precursors in the Subventricular Zone Without Affecting Their Long-Term Self-Renewal.

Authors:  Hongxin Chen; Matthew T Goodus; Sonia M de Toledo; Edouard I Azzam; Steven W Levison; Nizar Souayah
Journal:  ASN Neuro       Date:  2015-06-08       Impact factor: 4.146

9.  Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia.

Authors:  Sopio Simonishvili; Mohit Raja Jain; Hong Li; Steven W Levison; Teresa L Wood
Journal:  ASN Neuro       Date:  2013-12-23       Impact factor: 5.200

10.  Xenon Combined with Therapeutic Hypothermia Is Not Neuroprotective after Severe Hypoxia-Ischemia in Neonatal Rats.

Authors:  Hemmen Sabir; Damjan Osredkar; Elke Maes; Thomas Wood; Marianne Thoresen
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.